IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q3 2023
Institutional positions in IMMUTEP Ltd as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q2 2023
- Shares held
- 1.94M
- +320.0K (+19.8%) vs. Q2 2023
- Total value
- $3.68M
- +$269.0K (+7.9%) vs. Q2 2023
- New holders
- 4
- 8 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 786,605 | $1.49M | 0.00% | +615,447+359.6% | Added |
| Oracle Investment Management Inc | 516,430 | $981.2K | 1.51% | −377,961−42.3% | Reduced |
| Meridian Wealth Management, LLC | 311,200 | $591.3K | 0.04% | +48,150+18.3% | Added |
| Susquehanna International Group, LLP | 87,757 | $166.7K | 0.00% | +29,611+50.9% | Added |
| Dimensional Fund Advisors LP | 70,005 | $133.0K | 0.00% | −11,923−14.6% | Reduced |
| Verition Fund Management LLC | 30,000 | $57.0K | 0.00% | +8,000+36.4% | Added |
| Rhumbline Advisers | 26,243 | $49.9K | 0.00% | +380+1.5% | Added |
| BNP Paribas Arbitrage, SA | 23,935 | $45.5K | 0.00% | +14,700+159.2% | Added |
| Morgan Stanley | 22,794 | $43.3K | 0.00% | +300+1.3% | Added |
| Geode Capital Management, LLC | 18,722 | $35.6K | 0.00% | 00.0% | Unchanged |
| Integrated Advisors Network LLC | 13,000 | $24.7K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 12,001 | $23.0K | 0.00% | +12,001 | New |
| LPL Financial LLC | 10,650 | $20.2K | 0.00% | +10,650 | New |
| Citadel Advisors LLC | 4,332 | $8.23K | 0.00% | −4,190−49.2% | Reduced |
| Advisor Group Holdings, Inc. | 2,055 | $3.90K | 0.00% | +2,000+3,636.4% | Added |
| Cutler Group LP | 600 | $1.00K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 183 | $348 | 0.00% | +183 | New |
| Tower Research Capital LLC (TRC) | 36 | $68 | 0.00% | +36 | New |
| JPMorgan Chase & Co | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −25,646−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −506−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −60−100.0% | Sold out |